BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Grifols 

4560 Horton Street

Emeryville  California  94608-2916  U.S.A.
Phone: 510-655-8730 Fax: n/a


SEARCH JOBS



Grifols has a history of more than 70 years of commitment to transfusion medicine and patient safety. Our broad range of innovative diagnostic solutions plays a key role in ensuring the availability of safe and compatible blood products in markets worldwide. Active in all the different areas of transfusion safety, we provide products and systems for blood collection, typing, screening and traceability. Today, thousands of blood banks and transfusion services around the world trust in Grifols' diagnostic products.


 Key Statistics


Email:
Ownership: Public

Web Site: Grifols
Employees: 800
Symbol: GRFS
 



Industry
Diagnostics






 Company News
Plasma Medication Manufacturer Grifols Opens State-Of-The-Art Facility In North Carolina, 200 New Jobs On The Horizon 6/17/2014 11:13:20 AM
Grifols Completes Patient Enrollment In Its Phase2/3 Psoriasis Trial; Final Results Are Expected In Q1 2015 6/17/2014 10:50:26 AM
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM
TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols 11/22/2013 9:28:33 AM
Novartis AG (NVS) Sells Diagnostics Business Unit To Grifols For $1.68 Billion 11/11/2013 6:57:41 AM
Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting 10/4/2013 7:08:15 AM
Grifols and Aradigm Corporation (ARDM) Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin® 8/28/2013 10:38:04 AM
Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University 7/18/2013 9:28:30 AM
Grifols Study Demonstrates Higher Dose of PROLASTIN-C Increases Levels of Alpha1-PI to Within Normal Range in Patients With AAT Deficiency 5/22/2013 10:17:11 AM
Grifols Signs Deal to License Aradigm Corporation (ARDM)'s Pulmaquin for Up to $90.7 Million 5/21/2013 7:01:13 AM
123456